Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

The deal has taken a heavy toll on Illumina, whose business is otherwise lucrative thanks to its ubiquitous DNA sequencing machines. Grail’s greater-than-expected expenditures and delays in ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

“Without this machine, we can't do anything at the ... now the vice president and general manager of Illumina's DNA sequencing business unit following the acquisition of Solexa Ltd. by Illumina.

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with ...

With low machine costs, short sequencing time and reasonable amount of throughput, desktop sequencers such as Ion Torrent PGM, and its second-generation technology competitors, Illumina's MiSeq ...

The Invitrogen Collibri DNA Library Prep Kits prepare libraries for whole-genome sequencing (WGS) on Illumina NGS systems and contain tracking dyes to quickly and easily visualize library prep ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of California lost 18% and 15%, respectively. We recently published a list of Jim ...